eClinical Solutions appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer. Press Releases Released: March 12, 2026 Supporting 18 of the top 50 pharmaceutical companies in the world with its industry-leading clinical data intelligence platform, the company eyes its next phase of growth with expanded C-suite March 12, 2026, BOSTON - eClinical Solutions LLC, a global provider of digital clinical software and services, today announced two additions to its C-suite with the hiring of Lauren Whitsell as Chief Operating Officer and appointment of Venu Mallarapu as Chief Transformation and AI Officer. The news comes following a growth investment from GI Partners, signaling strong momentum as the company deepens its product roadmap, further embedding AI and risk-based capabilities, and ensures future-ready trials to drive tomorrow's breakthroughs. Whitsell brings over two decades of experience across technology and healthcare with a proven track record of operational leadership, scaling companies and systems, and driving improved performance. Whitsell holds a Bachelor of Business Administration in MIS & Mathematics from University of Notre Dame and a Master of Business Administration from Northwestern University's Kellogg School of Management. She joins eClinical Solutions after serving as Chief Product and Operations Officer at STARLIMS where she led an organization focused on improving product development, implementation, and support of the STARLIMS solution for customers globally. Prior to STARLIMS, she led operations at Appriss Health and Appriss Insights, before being acquired by Equifax Workforce Solutions. "As eClinical Solutions focuses on innovating the future of clinical trial automation, scaling operations and driving internal efficiencies that mirror the expectations of our customers is equally critical to maintaining our market-leading capabilities," said Lauren Whitsell, COO of eClinical Solutions. "I'm passionate about technology, efficiency, and growth that will support the end-to-end clinical research lifecycle." In her role, Whitsell will focus on executive leadership for all post-sale functions for the business, including professional services, implementation, support, training, adoption, and offshore operations, while championing a culture of high-quality customer service and operational excellence across the company. In his new role, Mallarapu will drive the company's AI-first strategy, ensuring technology and processes optimize AI and automation to support workforce transformation and deliver exceptional customer experience. Building on his tenure as Executive Vice President of Global Operations for eClinical Solutions, Mallarapu takes on expanded strategic responsibility. Under his leadership, eClinical Solutions' global delivery organization and partner ecosystem have scaled significantly, supporting the company's growth across 18 of the top 50 pharmaceutical companies worldwide. Together, the new appointees will support the long-term strategic pillars of the company amid rapid growth and scaling operations. "Over the last four years, I've seen firsthand how eClinical Solutions has evolved elluminate(R) to an end-to-end clinical data intelligence platform to achieve trial outcomes," said Venu Mallarapu, Chief Transformation and AI Officer at eClinical Solutions. "eClinical is shifting clinical data chaos into actionable decisions for biopharma leaders, especially in expanding our elluminate agents, which are fueled by data products with shared context and workflows and a foundation with grounding guardrails and policies. Internally, we are taking a similar approach to unite intentional AI strategy and innovation for operational transformation. I'm focused on building the AI and operational foundation that sets the standard for how clinical data companies run and win in the next decade." "When eClinical Solutions was founded in 2012, we had a vision to help solve the industry's clinical data challenges. We leveraged our deep expertise in clinical data and biometrics services to evolve the elluminate platform, enhanced by collaborations - including ZS and Snowflake - and driven by our expanding C-suite of experts," said Raj Indupuri, CEO and co-founder of eClinical Solutions. "Our infrastructure continues to scale, from deploying AI agents to enabling integrated risk management. We are committed to delivering value for biopharma and CRO organizations in alignment with our founding vision to help the life sciences industry reduce cycle times, improve quality, and bring breakthrough therapies to patients faster. I look forward to the support Lauren and Venu provide as we continue in our growth journey." About eClinical Solutions LLC. eClinical Solutions' industry-leading clinical data intelligence platform, elluminate(R), and biometrics services experts help biopharma researchers at large, mid-size, and emerging life sciences organizations develop tomorrow's breakthroughs with today's resources. eClinical is a privately-held, purpose-driven company with a global workforce and winner of the 2025 Top Workplace USA Award: Remote Work, the 2025 Top Workplaces Culture Excellence Award: Work-Life Flexibility, and Great Place To Work(R) India Certification(TM). Learn more at www.eclinicalsol.com and follow eClinical Solutions on LinkedIn.

eClinical Solutions highlights 2025 achievements and announces latest innovations to accelerate and future-proof clinical trials. Working with top global pharmaceutical sponsors, company doubles down on agentic AI and RBQM investments to bend the clinical development efficiency curve BOSTON-(BUSINESS WIRE)-eClinical Solutions LLC, a global provider of digital clinical software and services, today announced 2025 milestones along with new 2026 innovation to support the end-to-end clinical research lifecycle, bringing breakthrough therapies to patients faster. Last year the company added over 20 net new customers to its portfolio of biopharma and CRO clients, which now includes 18 of the top 50 pharmaceutical companies in the world, supporting clinical trial leaders with an AI-first, risk-based approach. Notably, eClinical Solutions focused on evolving elluminate as a clinical data intelligence platform to improve trial efficiency, debuting elluminate agents. The agents are fueled by data products with shared context and workflows with agentic, assistive, and task-oriented AI, and a data foundation with grounding guardrails and policies. Additionally, the company launched a digitized Integrated Data Review Plan (IDRP), positioning eClinical Solutions as the first company to centralize digital data review within a single platform, and announced an industry collaboration with ZS, pairing eClinical Solutions' elluminate RBQM (risk-based quality management) technology with ZS' RBQM consulting and custom-built solution expertise to create a unified integrated quality risk management (IQRM) experience for sponsors. Other key company highlights from 2025 included industry recognition in Everest Group's Tech Provider Spotlight: Risk-Based Quality Management (RBQM) report, highlighting eClinical Solutions' elluminate RBQM capabilities. eClinical Solutions also won the 2025 Top Workplace USA Award: Remote Work and the 2025 Top Workplaces Culture Excellence Award: Work-Life Flexibility, for the fourth consecutive year. Finally, the Society for Clinical Data Management (SCDM) awarded eClinical Solutions with the SCDM Innovation Award for Advancements in Health Insight Generation and elected Dawn Kaminski, Vice President of Business Development Operations at eClinical Solutions as Executive Secretary of the SCDM Board for 2026. Building on 2025 momentum, the company has unveiled new updates to the elluminate platform this year aimed at supporting sponsors' objectives - from ensuring ease of compliance with the revised ICH E6 R(3) guidelines to expanding agentic AI efficiencies: * Agentic data review automation: The Explain Agent in Data Central uses clinical data and protocol-aware intelligence to interpret charts in real time, highlight meaningful patterns, and recommend next steps, eliminating hours of manual navigation by delivering instant, explainable insights where reviewers work. * End-to-end RBQM traceability: RACT integration into review objectives plus RBQM Snapshots to preserve evidence over time, improve audit readiness, and strengthen follow-up execution. * Faster, more consistent RBQM setup: Study-level RBQM configuration with linkage to global KRIs/QTLs and the ability to auto-pull KRIs/QTLs from RACT, reducing manual effort and accelerating study startup. * Guided centralized monitoring experience: In-context KRI/QTL/risk signal review - thresholds, recommendations, related observations - directly from the RBQM Overview to drive faster, more consistent decisions. * Agentic SDTM mapping automation from spec to executable code: Automated and agentic-AI-powered specification generation, plus transparent code generation - Python/R/SAS - with traceability from spec through execution logs to accelerate submission-ready datasets. "Insight from clients and partners at ENGAGE 2025 and the data from our 2025 Industry Outlook Survey reaffirmed our conviction of creating a strong data intelligence foundation through the elluminate platform that elicits scalable innovation, from embedding intelligence to risk-based approaches," said Raj Indupuri, CEO and co-founder of eClinical Solutions. "As we look at our next phase of growth, we're hyper-focused on driving return on investment for our clients and leaning into agentic AI in 2026, for the next era of clinical trial automation." About eClinical Solutions LLC eClinical Solutions' industry-leading clinical data intelligence platform, elluminate(R), and biometrics services experts help biopharma researchers at large, mid-size, and emerging life sciences organizations develop tomorrow's breakthroughs with today's resources. eClinical is a privately-held, purpose-driven company with a global workforce and winner of the 2025 Top Workplace USA Award: Remote Work, the 2025 Top Workplaces Culture Excellence Award: Work-Life Flexibility, and Great Place To Work(R) India Certification(TM). Learn more at www.eclinicalsol.com and follow eClinical Solutions on LinkedIn.

eClinical Solutions, a global provider of digital clinical software and services, has added over 20 new customers in 2025, bringing its client portfolio to 18 of the top 50 pharmaceutical companies worldwide. The company evolved its elluminate platform into a clinical data intelligence system, launching elluminate agents powered by AI and a digitised Integrated Data Review Plan. The Boston-based firm received industry recognition in Everest Group's RBQM report and won the 2025 Top Workplace USA Award for Remote Work. For 2026, eClinical Solutions unveiled platform updates including agentic data review automation, end-to-end RBQM traceability, and automated SDTM mapping. The company announced a collaboration with ZS to create an integrated quality risk management experience for sponsors.